EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy

Bryan Marr iD, Donghyeon Jo iD, Mihue Jang iD, Seung-Hwan Lee iD

Immune Network · 2025 · 25 (2)

DOI: 10.4110/in.2025.25.e17 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immune Network, 2025. Verfasst von Bryan Marr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NK cell adoptive cell therapy (ACT) has emerged as a promising strategy for cancer immunotherapy, offering advantages in scalability, accessibility, efficacy, and safety. Ex vivo activation and expansion protocols, incorporating feeder cells and cytokine cocktails, have enabled the production of highly functional NK cells in clinically relevant quantities. Advances in NK cell engineering, including CRISPR-mediated gene editing and chimeric Ag receptor technologies, have further enhanced cytotoxicity, persistence, and tumor targeting. Cytokine support post-adoptive transfer, particularly with IL-2 and IL-15, remains critical for promoting NK cell survival, proliferation, and anti-tumor activity despite persistent challenges such as regulatory T cell expansion and cytokine-related toxicities. This review explores the evolving roles of IL-2 and IL-15 in NK cell-based ACT, evaluating their potential and limitations, and highlights strategies to optimize these cytokines for effective cancer immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

Cancer immunotherapyCytokineIL-15IL-2Natural killer cell

Autor:innen und Institutionen

  • Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
  • Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology, Seoul 02792, Korea.
  • KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul 02447, Korea.
  • Ottawa Institute of Systems Biology, Faculty of Medicine and Centre for Infection, Immunity, and Inflammation, Faculty of Medicine, University of Ottawa, ON K1H 8M5, Canada.

ORCID-Profile: Bryan Marr, Donghyeon Jo, Mihue Jang, Seung-Hwan Lee

Förderung

  • National Research Foundation of Korea
  • Canadian Institutes of Health Research

Zitieren

APA

Marr, B., Jo, D., Jang, M., & Lee, S. H. (2025). Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy. Immune Network, 25(2). https://doi.org/10.4110/in.2025.25.e17

Vancouver

Marr B, Jo D, Jang M, Lee SH. Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy. Immune Network. 2025;25(2). doi:10.4110/in.2025.25.e17

BibTeX
@article{Marr2025,
  author = {Marr, Bryan and Jo, Donghyeon and Jang, Mihue and Lee, Seung-Hwan},
  title = {Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy},
  journal = {Immune Network},
  year = {2025},
  volume = {25},
  number = {2},
  doi = {10.4110/in.2025.25.e17}
}
Kostenlos starten →